These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 19389494

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Multiple myeloma international staging system: "staging" or simply "aging" system?
    Bataille R, Annweiler C, Beauchet O.
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):635-7. PubMed ID: 24035714
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. International Staging System required standardization of biochemical laboratory testing in multiple myeloma.
    Tichý M, Maisnar V, Palicka V, Friedecký B, Vávrová J, Novotná H, Cermáková Z, Dastych M, Cechák P, Vogtová D, Jarolímková E, Benáková H, Hachová L, Bezdícková D, Kouril F, Zábranská EA, Zenková J, Slabý P, Scudla V, Gregora E, Spicka I, Straub J, Schützova M, Hájek R.
    Neoplasma; 2006 Dec; 53(6):492-4. PubMed ID: 17167717
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Prognostic factors of multiple myeloma].
    Paule B.
    Ann Med Interne (Paris); 1997 Dec; 148(8):534-41. PubMed ID: 9538400
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
    Rajkumar SV, Buadi F.
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.
    Sagaster V, Kaufmann H, Odelga V, Ackermann J, Gisslinger H, Rabitsch W, Zojer N, Ludwig H, Nösslinger T, Zielinski C, Drach J.
    Eur J Haematol; 2007 Mar; 78(3):227-34. PubMed ID: 17253972
    [Abstract] [Full Text] [Related]

  • 32. [Prognositic factors in multiple myeloma].
    Nagura E.
    Nihon Rinsho; 2007 Dec; 65(12):2351-6. PubMed ID: 18069282
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.
    Kasamatsu T, Ozaki S, Saitoh T, Konishi J, Sunami K, Itagaki M, Asaoku H, Cho T, Handa H, Hagiwara S, Wakayama T, Negoro A, Takezako N, Harada N, Kuroda Y, Nakaseko C, Miyake T, Inoue N, Hata H, Shimazaki C, Ohno T, Kuroda J, Murayama T, Kobayashi T, Abe M, Ishida T, Nagura E, Shimizu K.
    Hematol Oncol; 2018 Dec; 36(5):792-800. PubMed ID: 30176173
    [Abstract] [Full Text] [Related]

  • 36. Critical considerations on a comparative study of two staging systems for multiple myeloma.
    Merlini G, Jayakar D.
    Nouv Rev Fr Hematol (1978); 1984 Dec; 26(6):397-400. PubMed ID: 6527945
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prognostic significance of the serum phosphorus level and its relationship with other prognostic factors in multiple myeloma.
    Umeda M, Okuda S, Izumi H, Nagase D, Fujimoto Y, Sugasawa Y, Arai C, Natori K, Katoh M, Kuraishi Y.
    Ann Hematol; 2006 Jul; 85(7):469-73. PubMed ID: 16528526
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.